AS1269574 is a potent, orally available GPR119 agonist, with an EC50 of 2.5 μM in HEK293 cells expressing human GPR119. AS1269574 activates TRPA1 cation channels to stimulate glucagon-like peptide-1 (GLP-1) secretion. AS1269574 specifically induces glucose-dependent insulin secretion from pancreatic β-cells only under high-glucose conditions. AS1269574 has the potential for the research of type 2 diabetes.
性状
Solid
IC50 & Target[1][2]
TRPA1
GPR119
体内研究(In Vivo)
AS1269574 sgnificantly reduced the blood glucose AUC after 2 h (AUC0-2h) of administration.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model:
Eight-week-old ICR mice
Dosage:
100 mg/kg
Administration:
P.o.
Result:
Sgnificantly reduced the blood glucose AUC after 2 h (AUC0-2h) of administration. Similarly, plasma insulin AUC0-2h was significantly higher in the mice.